Totally thoracoscopic beating-heart tricuspid valve repair 30 years after Ebstein’s anomaly surgery: a case report and literature review Authors: Lipeng Li, Wen Zhao, Chusheng Huang, Xiaohan Bi, Hailong Deng, Dunbo Yi, Pei Tan, Lei Xian Published: 2026 ABSTRACT BackgroundEbstein’s anomaly is a rare congenital malformation of the tricuspid valve that frequently progresses to severe tricuspid regurgitation and right-sided heart failure. Although early surgical repair can provide durable clinical improvement, late recurrent tricuspid regurgitation is not uncommon and may require technically challenging reoperation. In this setting, minimally invasive thoracoscopic beating-heart repair may offer an alternative to redo sternotomy, particularly for high-risk patients.Case presentationA 50-year-old woman with congenital tricuspid valve disease had previously undergone De Vega annuloplasty for Ebstein’s anomaly at age 19. After more than three decades of clinical stability, progressive exertional dyspnea (New York Heart Association class III), abdominal distension, and bilateral leg edema developed. Evaluation demonstrated massive right atrial enlargement, severe tricuspid regurgitation, preserved left ventricular systolic function, and findings consistent with congestive hepatopathy. Following multidisciplinary evaluation, redo tricuspid valve repair was performed through a totally thoracoscopic right-sided approach using femoro-femoral cardiopulmonary bypass on a beating heart. The anterior and posterior leaflets were mobilized and augmented with a bovine pericardial patch to create a cone-like leaflet configuration, and a 30-mm annuloplasty ring was implanted. Intraoperative transesophageal echocardiography demonstrated trivial residual tricuspid regurgitation. Recovery was uneventful, and the patient was discharged on postoperative day 10. At 3-month follow-up, functional capacity improved, and echocardiography showed mild tricuspid regurgitation with reduced right-sided chamber dimensions. At the latest follow-up, 20 months after surgery, moderate residual tricuspid regurgitation persisted, while right-sided chamber dimensions remained reduced (right atrial transverse diameter, 64 mm; right ventricular transverse diameter, 44 mm). Chest radiography also showed persistent cardiomegaly, although it remained improved compared with the preoperative study.ConclusionsThis case shows that totally thoracoscopic beating-heart tricuspid valve re-repair can be technically feasible in selected patients with late recurrent tricuspid regurgitation after prior Ebstein’s anomaly surgery. In this patient, early postoperative improvement was substantial, although extended follow-up demonstrated partial loss of the initial echocardiographic benefit, highlighting the need for continued surveillance and cautious interpretation of long-term durability. Introduction Despite significant progress in anatomic repair, late failure after Ebstein’s anomaly (EA) surgery still occurs and most commonly manifests as progressive, symptomatic tricuspid regurgitation (TR) necessitating reintervention [1]. Redo tricuspid operations are often technically demanding, especially in patients with prior sternotomy, substantial right-sided enlargement, or markedly altered leaflet morphology [2]. In recent years, minimally invasive, beating-heart techniques have emerged as a compelling option for selected reoperative cases, providing safe exposure while avoiding the morbidity associated with resternotomy [3]. Here, we describe a patient who presented with recurrent severe TR more than three decades after De Vega annuloplasty for EA and underwent successful totally thoracoscopic, beating-heart tricuspid valve re-repair using a cone-type reconstruction. Case presentation Patient information A 50-year-old woman was evaluated in early 2024 for a one-year history of exertional dyspnea, abdominal distension, and bilateral lower-limb edema. Symptoms fluctuated throughout the year, with repeated hospitalizations at local facilities providing only transient improvement before recurrence. Approximately one month before referral, a clear deterioration occurred, characterized by worsening exertional dyspnea, increased abdominal distension, and recurrent lower-limb edema. The patient had undergone open-heart surgery at age 19 for congenital tricuspid valve disease, described in the operative note as De Vega annuloplasty for EA without implantation of prosthetic material. The patient remained clinically stable for several decades following the initial repair. The medical history also included chronic hepatitis C infection and cardiac cirrhosis, for which no standardized antiviral or hepatic therapy had been administered. At presentation, the patient was classified as New York Heart Association (NYHA) class III. Vital signs showed a blood pressure of 93/65 mmHg, an irregular heart rate of 90 beats/min, a respiratory rate of 20 breaths/min, and an oxygen saturation of 97% on room air. Physical examination revealed marked jugular venous distension, a prominent right ventricular (RV) impulse, and a grade 4/6 holosystolic murmur at the lower left sternal border that intensified with inspiration. Abdominal examination demonstrated distension with shifting dullness consistent with ascites, and bilateral pitting edema was present to the level of the knees. Preoperative findings Laboratory evaluation demonstrated normocytic anemia (hemoglobin 95 g/L), hypoalbuminemia (19.7 g/L), and low total protein (35 g/L), findings consistent with chronic systemic congestion and malnutrition. N-terminal pro–brain natriuretic peptide was elevated at 1344 pg/mL. Serologic testing was positive for chronic hepatitis C. Electrocardiography revealed atrial fibrillation with incomplete right bundle branch block. Right heart catheterization demonstrated mildly elevated pulmonary artery pressure at 20/7 mmHg (mean 14 mmHg). The mean right ventricular (RV) pressure was 9 mmHg, and the mean right atrium (RA) pressure was 8 mmHg. In the setting of massive right atrium (RA) enlargement and torrential tricuspid regurgitation (TR), this hemodynamic pattern was consistent with chronic right-sided volume overload and reduced right atrial compliance. Chest radiography demonstrated massive cardiomegaly (cardiothoracic ratio ~ 0.80) with a globular silhouette dominated by an enlarged right atrium (RA) and a small right pleural effusion (Fig. 1A). Computed tomography (CT) further confirmed marked cardiomegaly with disproportionate right atrial enlargement. Dilatation of the left and middle hepatic veins, inferior vena cava, bilateral renal veins, and bilateral ovarian veins was evident, consistent with severe systemic venous congestion. Imaging features of cardiac cirrhosis were also present. Fig. 1Serial chest radiographs before and after redo tricuspid repair. (A) Preoperative posteroanterior chest radiograph showing marked cardiomegaly (cardiothoracic ratio ≈ 0.80) with a globular cardiac silhouette predominantly due to right atrial enlargement and mild pulmonary congestion. (B) Posteroanterior chest radiograph at 3-month follow-up demonstrating a clear reduction in cardiac size (cardiothoracic ratio ≈ 0.65) with improved right heart contour and clear lung fields. (C) Posteroanterior chest radiograph at 20-month follow-up showing persistent cardiomegaly (cardiothoracic ratio ≈ 0.70), slightly increased compared with the 3-month study but still improved relative to the preoperative examination Serial chest radiographs before and after redo tricuspid repair. (A) Preoperative posteroanterior chest radiograph showing marked cardiomegaly (cardiothoracic ratio ≈ 0.80) with a globular cardiac silhouette predominantly due to right atrial enlargement and mild pulmonary congestion. (B) Posteroanterior chest radiograph at 3-month follow-up demonstrating a clear reduction in cardiac size (cardiothoracic ratio ≈ 0.65) with improved right heart contour and clear lung fields. (C) Posteroanterior chest radiograph at 20-month follow-up showing persistent cardiomegaly (cardiothoracic ratio ≈ 0.70), slightly increased compared with the 3-month study but still improved relative to the preoperative examination Transthoracic echocardiography (TTE) demonstrated striking right atrium (RA) enlargement (transverse diameter 78 mm; long-axis length 112 mm) and a markedly dilated right ventricular (RV) with preserved systolic function. The septal tricuspid leaflet was apically displaced, the anterior leaflet appeared excessively large, thin, and fenestrated, and the posterior leaflet was small and tethered—features consistent with EA. No annuloplasty ring was identified; instead, a circumferential fibrotic ridge along the annulus corresponded to the prior De Vega repair. Color Doppler imaging revealed torrential central tricuspid regurgitation (TR) filling nearly the entire right atrium (RA) cavity, with an instantaneous regurgitant volume of 182 mL that underscored the severity of right-sided volume overload and its hemodynamic significance (Fig. 2A). Estimated right ventricular (RV) systolic pressure was approximately 40 mmHg. Left ventricular (LV) size and systolic function remained within normal limits. Fig. 2Serial transthoracic echocardiography before and after redo tricuspid repair. (A) Preoperative apical four-chamber color Doppler view showing torrential central tricuspid regurgitation with marked right atrial and right ventricular dilatation. (B) Transthoracic echocardiography at 3-month follow-up demonstrating mild residual tricuspid regurgitation with reduced right atrial and right ventricular dimensions and preserved left ventricular systolic function. (C) Transthoracic echocardiography at 20-month follow-up demonstrating moderate residual tricuspid regurgitation, while right-sided chamber dimensions remained improved compared with the preoperative examination Serial transthoracic echocardiography before and after redo tricuspid repair. (A) Preoperative apical four-chamber color Doppler view showing torrential central tricuspid regurgitation with marked right atrial and right ventricular dilatation. (B) Transthoracic echocardiography at 3-month follow-up demonstrating mild residual tricuspid regurgitation with reduced right atrial and right ventricular dimensions and preserved left ventricular systolic function. (C) Transthoracic echocardiography at 20-month follow-up demonstrating moderate residual tricuspid regurgitation, while right-sided chamber dimensions remained improved compared with the preoperative examination Preoperative discussion Given the history of prior repair for EA, severe symptomatic tricuspid regurgitation (TR), preserved right ventricular (RV) systolic function, and the absence of prohibitive pulmonary hypertension, the clinical presentation met guideline-supported indications for surgical intervention [4, 5]. Although atrial fibrillation, chronic hepatitis C, and previous sternotomy increased operative risk, evaluation by a multidisciplinary heart team deemed reoperation feasible. A minimally invasive right thoracoscopic redo tricuspid valve repair on a beating heart was recommended, with valve repair favored over replacement. Operative findings Cardiopulmonary bypass (CPB) was established through femoral arterial and venous cannulation with supplemental drainage from the right internal jugular vein, and a longitudinal right atriotomy was performed under mild hypothermia. The superior and inferior vena cavae were not snared or directly occluded. Venous return was maintained with vacuum-assisted venous drainage through femoral venous cannulation supplemented by right internal jugular drainage. During the right atrial phase of the beating-heart repair, blood returning from the coronary sinus was managed with continuous suction using a dedicated intracardiac sucker introduced through the working port into the right atrium via the right atriotomy. Thoracoscopic inspection revealed a markedly enlarged right atrium (RA) and a redundant anterior leaflet with multiple fenestrations, along with hypoplastic septal and posterior leaflets (Fig. 3A). The tricuspid annulus was severely dilated, and fibrotic tissue consistent with the previous De Vega annuloplasty was present along the annular contour; no annuloplasty ring was identified. Right ventricular (RV) contractility remained preserved despite chamber enlargement. Fig. 3Intraoperative thoracoscopic views of the tricuspid valve. (A) Redundant anterior leaflet with fenestrations and poor coaptation. (B) Cone reconstruction with extensive leaflet mobilization. (C) Ring annuloplasty with annular sutures in place. (D) Competent tricuspid valve after completed repair Intraoperative thoracoscopic views of the tricuspid valve. (A) Redundant anterior leaflet with fenestrations and poor coaptation. (B) Cone reconstruction with extensive leaflet mobilization. (C) Ring annuloplasty with annular sutures in place. (D) Competent tricuspid valve after completed repair Surgical technique A totally thoracoscopic beating-heart approach was employed using three right thoracic ports: a 4-cm working incision in the fourth intercostal space along the right anterior axillary line, a 1-cm thoracoscopic port in the fifth intercostal space at the right mid-axillary line, and a 1-cm auxiliary port in the third intercostal space. Cone-like reconstruction was initiated by widely mobilizing the anterior and posterior leaflets from the annulus between the 9-o’clock and 3-o’clock positions while preserving all chordal attachments to restore leaflet mobility (Fig. 3B). The anterior leaflet fenestrations were closed, but the mobilized leaflets remained insufficient in height and surface area to achieve a stable coaptation zone. Leaflet augmentation was therefore performed using a tailored glutaraldehyde-treated bovine pericardial patch, which was shaped and sewn to the leaflet edges to enlarge the functional leaflet surface and establish a broad, continuous coaptation line. Annular remodeling was completed with implantation of a 30-mm semirigid Edwards annuloplasty ring (model 6200T30) secured circumferentially with pledgeted sutures to restore physiologic annular geometry and ensure durable stabilization (Fig. 3C). The ring size was determined intraoperatively using a standard tricuspid annuloplasty sizer after leaflet mobilization and reconstruction, based on the reconstructed annular geometry and anticipated leaflet coaptation rather than the prior De Vega procedure. Saline testing demonstrated satisfactory leaflet excursion and a well-formed coaptation line with only trace residual regurgitation (Fig. 3D). After separation from cardiopulmonary bypass, intraoperative transesophageal echocardiography (TEE) confirmed normal leaflet mobility and mild tricuspid regurgitation (TR), with an instantaneous regurgitant volume of 7.74 mL and no evidence of stenosis. The total operative time was 342 min, cardiopulmonary bypass time was 263 min, and estimated blood loss was 300 mL. Intraoperatively, 2 units of leukocyte-reduced packed red blood cells and 200 mL of fresh frozen plasma were transfused. Postoperative course and follow-up The postoperative course was notable for discontinuation of mechanical ventilation on postoperative day (POD) 2, followed by tracheal extubation. The patient was transferred from the intensive care unit (ICU) to the general ward on POD 4, at which time chest tubes were also removed. No arrhythmic or bleeding complications occurred during early recovery. Diuretic therapy, hepatoprotective management, and nutritional support were optimized throughout hospitalization. The patient was discharged home on POD 10 without adverse events. At the 3-month follow-up, the patient reported substantial improvement in exertional tolerance, with functional capacity consistent with NYHA class I–II and no recurrence of edema or ascites. Physical examination showed no jugular venous distension, and only a soft systolic murmur remained. Chest radiography demonstrated a reduction in cardiomegaly, with the cardiothoracic ratio decreasing to approximately 0.65 (Fig. 1B). Transthoracic echocardiography (TTE) showed restored leaflet coaptation with mild residual tricuspid regurgitation (TR) and significant reductions in right atrial (RA) and right ventricular (RV) chamber dimensions (Fig. 2B). At the latest follow-up, 20 months after surgery, TTE demonstrated moderate residual TR with a regurgitant volume of approximately 43 mL. The right atrial transverse diameter was 64 mm, and the right ventricular transverse diameter remained 44 mm. TAPSE was 19 mm, and left ventricular systolic function remained preserved, with an ejection fraction of 66%. Chest radiography showed persistent cardiomegaly, with a cardiothoracic ratio of approximately 0.70, which was slightly increased compared with the 3-month examination but remained improved relative to the preoperative study (Figs. 1C and 2C). Overall, the early postoperative improvement was partially maintained during extended follow-up. Serial echocardiographic and chest radiographic findings are summarized in Table 1. Table 1Serial echocardiographic and chest radiographic findingsParameterPreoperative3-month follow-up20-month follow-upCardiothoracic ratio0.800.650.70RA transverse diameter, mm786164RA longitudinal diameter, mm112NRNRRV transverse diameter, mm654444TR severitySevereMildModerateTR regurgitant volume, mL1822443TAPSE, mm21719Estimated PASP, mmHg404043LVEF, %536266RA, right atrial; RV, right ventricular; TR, tricuspid regurgitation; TAPSE, tricuspid annular plane systolic excursion; PASP, pulmonary artery systolic pressure; LVEF, left ventricular ejection fraction; NR, not reported Table 1Serial echocardiographic and chest radiographic findingsParameterPreoperative3-month follow-up20-month follow-upCardiothoracic ratio0.800.650.70RA transverse diameter, mm786164RA longitudinal diameter, mm112NRNRRV transverse diameter, mm654444TR severitySevereMildModerateTR regurgitant volume, mL1822443TAPSE, mm21719Estimated PASP, mmHg404043LVEF, %536266RA, right atrial; RV, right ventricular; TR, tricuspid regurgitation; TAPSE, tricuspid annular plane systolic excursion; PASP, pulmonary artery systolic pressure; LVEF, left ventricular ejection fraction; NR, not reported Serial echocardiographic and chest radiographic findings RA, right atrial; RV, right ventricular; TR, tricuspid regurgitation; TAPSE, tricuspid annular plane systolic excursion; PASP, pulmonary artery systolic pressure; LVEF, left ventricular ejection fraction; NR, not reported Discussion and literature review Late recurrent tricuspid regurgitation (TR) after surgical repair for Ebstein’s anomaly (EA) remains a challenging clinical entity, even in patients who have enjoyed decades of postoperative stability. Earlier surgical strategies such as De Vega annuloplasty, while effective in the short to intermediate term, lack durable annular stabilization and may predispose to progressive annular dilatation and late valve failure [6, 7]. As increasingly recognized in contemporary series [8, 9], recurrent severe TR is not merely a benign echocardiographic finding but a progressive disease process that drives right atrial (RA) and right ventricular (RV) remodeling, atrial arrhythmias, hepatic congestion, and ultimately right-sided heart failure with excess late mortality. The present case is notable for very late recurrent torrential tricuspid regurgitation more than 30 years after De Vega annuloplasty for Ebstein’s anomaly, managed with totally thoracoscopic beating-heart re-repair using cone-like reconstruction, bovine pericardial patch augmentation, and ring annuloplasty. Late failure after Ebstein’s anomaly repair: mechanisms and clinical implications The pathophysiology of late TR after EA repair is widely recognized as multifactorial, involving persistent leaflet dysplasia, an unfavorable leaflet-to-annulus ratio, progressive annular dilatation, and adverse right ventricular remodeling, all of which predispose to late leaflet malcoaptation [10, 11]. In particular, suture-based annuloplasty techniques without prosthetic ring support have been consistently associated with late annular redilatation and recurrent TR [7]. This case illustrates the extreme end of this spectrum, with torrential TR presenting more than 30 years after De Vega annuloplasty, accompanied by massive RA enlargement, atrial fibrillation, ascites, peripheral edema, and congestive hepatopathy. Several large observational studies and registry analyses have consistently demonstrated that symptomatic severe tricuspid regurgitation is independently associated with reduced long-term survival, frequent heart failure hospitalization, and impaired quality of life when managed conservatively [8, 12–14]. Accordingly, contemporary international guidelines now advocate timely surgical intervention for severe primary tricuspid regurgitation in symptomatic patients, preferably before the development of irreversible right ventricular dysfunction or advanced end-organ damage, in order to optimize postoperative outcomes and long-term prognosis [4, 5]. In the present case, the absence of significant pulmonary hypertension and the preservation of right ventricular function supported operative intervention, despite advanced systemic congestion. Re-repair versus replacement in redo tricuspid surgery A key issue in the management of late failure after EA repair is whether redo surgery should favor tricuspid valve replacement or re-repair. Accumulating evidence indicates that, whenever technically feasible, tricuspid valve repair is associated with lower perioperative mortality and superior long-term outcomes compared with valve replacement, particularly in isolated and reoperative tricuspid procedures [2, 15, 16]. In contrast, prosthetic valve replacement carries inherent risks, including structural valve degeneration, thromboembolic complications, prosthetic valve endocarditis, and pacemaker lead–prosthesis interaction, considerations that are especially relevant in younger and middle-aged patients with congenital heart disease [4, 17]. The development of cone reconstruction has markedly changed the surgical approach to EA by promoting an anatomic repair concept based on extensive leaflet mobilization and circumferential valve reconstruction. Clinical series published over the past decade have shown that this technique can effectively restore near-physiologic tricuspid valve function, yielding excellent early hemodynamic performance, durable reduction of tricuspid regurgitation (TR), and favorable mid- to long-term outcomes [18–20]. Importantly, emerging evidence suggests that these principles are not limited to primary repair, as selected patients with failed prior non-cone procedures may still be suitable candidates for anatomic re-repair when sufficient leaflet tissue can be mobilized and, if required, augmented [21]. In this patient, intraoperative inspection revealed a redundant but fenestrated anterior leaflet with hypoplastic posterior and septal leaflets, severe annular dilatation, and fibrotic changes from prior suture annuloplasty. Rather than abandoning repair due to leaflet deficiency, a cone-like re-repair strategy was adopted, combining wide leaflet mobilization, fenestration closure, pericardial patch augmentation to increase effective leaflet area, and rigid annular remodeling with a prosthetic ring. This approach aligns with growing evidence supporting repair-centered strategies even in complex redo scenarios [22]. Transcatheter therapy was also considered, but it was not regarded as the optimal option in this patient. Current tricuspid transcatheter interventions remain highly dependent on anatomical suitability and expert-center availability [23, 24]. In the present case, prior De Vega annuloplasty, severe annular dilatation, leaflet fenestration, and the need for direct leaflet mobilization and patch augmentation favored surgical re-repair over a transcatheter approach [23–25]. Economic and access considerations were additional practical limitations [26]. Minimally invasive and beating-heart strategies in redo tricuspid surgery As a result, right-sided minimally invasive thoracic approaches have been increasingly adopted for reoperative tricuspid valve surgery, as accumulating evidence has shown that these techniques are associated with reduced surgical trauma, a favorable perioperative risk profile, and more rapid postoperative recovery [3, 27, 28]. In the redo setting, avoidance of repeat sternotomy mitigates the risk of right ventricular injury during re-entry, limits extensive adhesiolysis, and has been associated with improved early clinical recovery—an important consideration in patients who frequently present with diminished functional reserve and advanced right-sided heart failure [29, 30]. Beating-heart techniques further reduce procedural invasiveness by obviating aortic cross-clamping and cardioplegic arrest, thereby preserving continuous coronary perfusion and avoiding global myocardial ischemia. By eliminating ischemia–reperfusion injury, this strategy may offer meaningful myocardial protection and facilitate early postoperative recovery of cardiac function. These advantages are particularly relevant in patients with advanced right-sided heart failure, hepatic congestion, malnutrition, or limited physiologic reserve, in whom myocardial tolerance to ischemic stress is often reduced [15]. In the present case, femoro-femoral cardiopulmonary bypass (CPB) with supplemental jugular venous drainage provided effective cardiac decompression and operative exposure, enabling a complex reconstructive repair to be completed entirely thoracoscopically on a beating heart while maintaining stable intraoperative hemodynamics. Technical considerations in complex redo repair Several operative principles highlighted in the literature were central to achieving an effective early repair in this complex redo case and may be relevant to longer-term durability [6, 18, 19, 31–33]. First, extensive leaflet mobilization with meticulous preservation of chordal attachments was essential to restore leaflet mobility and re-establish functional valvular geometry. Second, leaflet augmentation was employed to address inadequate native leaflet tissue resulting from long-standing abnormal loading conditions and prior repair, thereby ensuring an adequate leaflet-to-annulus ratio and effective coaptation. Third, implantation of a rigid or semirigid annuloplasty ring was critical for correcting severe annular dilatation and providing long-term annular stabilization to prevent late redilatation. Finally, systematic intraoperative echocardiographic assessment allowed real-time evaluation of leaflet coaptation, transvalvular gradients, and residual regurgitation, ensuring an optimal repair without functional stenosis. Consistent with these technical principles, intraoperative TEE demonstrated trivial residual TR, and early follow-up imaging showed mild residual TR with marked reductions in right atrial and right ventricular dimensions, indicating effective early reverse right-sided remodeling. However, at the latest follow-up, 20 months after surgery, residual TR had increased to a moderate degree, although right-sided chamber dimensions remained improved compared with the preoperative findings, suggesting that the early benefit was only partially maintained during extended follow-up. Impact of tricuspid repair on systemic congestion Chronic severe tricuspid regurgitation is frequently associated with progressive systemic venous congestion, manifesting as congestive hepatopathy, hypoalbuminemia, and ascites, all of which substantially increase perioperative risk. Increasing evidence suggests that effective correction of tricuspid regurgitation (TR) may lead to gradual improvement in hepatic congestion and related systemic symptoms, particularly when intervention is undertaken before the development of irreversible cardiac cirrhosis [34, 35]. In the present case, resolution of ascites and peripheral edema, together with improved functional capacity during follow-up, is consistent with the concept that timely tricuspid valve repair can alleviate systemic consequences of right-sided heart failure. Limitations This report describes a single case and therefore cannot establish generalizability or superiority over alternative approaches. Although follow-up was extended to 20 months after surgery, the increase in residual tricuspid regurgitation from mild to moderate indicates that long-term durability remains uncertain and requires further observation. Nevertheless, this case adds to the growing body of literature supporting minimally invasive, repair-oriented strategies for TR after EA surgery. Conclusions Totally thoracoscopic beating-heart tricuspid valve re-repair with cone-like reconstruction and leaflet augmentation was technically feasible in this patient with torrential TR occurring three decades after De Vega annuloplasty for Ebstein’s anomaly. The procedure achieved substantial early clinical and echocardiographic improvement, but long-term durability remains uncertain and continued follow-up is required.